Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Aarti Surfactant
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 157.84 | 148.70 | 143.86 | 138.75 | 158.55 | 143.41 | 150.84 | 162.78 | 202.05 | 215.90 | 179.17 | 207.79 | 256.28 |
| Expenses + | 143.94 | 133.90 | 127.60 | 122.02 | 144.21 | 133.79 | 147.12 | 153.89 | 182.36 | 204.27 | 169.83 | 195.10 | 243.07 |
| Operating Profit | 13.90 | 14.80 | 16.26 | 16.73 | 14.34 | 9.62 | 3.72 | 8.89 | 19.69 | 11.63 | 9.34 | 12.69 | 13.21 |
| OPM % | 8.81% | 9.95% | 11.30% | 12.06% | 9.04% | 6.71% | 2.47% | 5.46% | 9.75% | 5.39% | 5.21% | 6.11% | 5.15% |
| Other Income + | 0.09 | 0.03 | 0.03 | 0.03 | 0.05 | 0.49 | 6.21 | -0.16 | 1.14 | 0.04 | 0.06 | 0.04 | 0.19 |
| Interest | 3.91 | 3.32 | 3.66 | 3.65 | 3.41 | 2.57 | 2.60 | 3.12 | 3.26 | 3.28 | 2.80 | 3.16 | 3.06 |
| Depreciation | 3.93 | 3.95 | 3.85 | 4.02 | 4.21 | 4.23 | 4.31 | 4.40 | 4.41 | 4.35 | 4.41 | 4.47 | 4.46 |
| Profit before tax | 6.15 | 7.56 | 8.78 | 9.09 | 6.77 | 3.31 | 3.02 | 1.21 | 13.16 | 4.04 | 2.19 | 5.10 | 5.88 |
| Tax % | 23.90% | 30.56% | 45.90% | 26.40% | 31.17% | 32.93% | 40.07% | 33.88% | 26.22% | 27.23% | 29.22% | 28.24% | 28.74% |
| Net Profit + | 4.69 | 5.25 | 4.74 | 6.68 | 4.65 | 2.22 | 1.81 | 0.80 | 9.72 | 2.94 | 1.56 | 3.66 | 4.19 |
| EPS in Rs | 5.52 | 6.18 | 5.58 | 7.86 | 5.50 | 2.62 | 2.14 | 0.95 | 11.49 | 3.48 | 1.84 | 4.32 | 4.95 |
Financials of Aarti Surfactant
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 326 | 466 | 576 | 601 | 590 | 659 | 859 |
| Expenses + | 302 | 420 | 543 | 554 | 528 | 617 | 812 |
| Operating Profit | 24 | 46 | 32 | 48 | 62 | 42 | 47 |
| OPM % | 7% | 10% | 6% | 8% | 11% | 6% | 5% |
| Other Income + | 0 | 0 | 0 | 0 | 0 | 8 | 0 |
| Interest | 10 | 10 | 11 | 15 | 14 | 12 | 12 |
| Depreciation | 11 | 12 | 12 | 15 | 16 | 17 | 18 |
| Profit before tax | 3 | 23 | 9 | 18 | 32 | 21 | 17 |
| Tax % | 29% | 6% | 41% | 29% | 34% | 30% | 28% |
| Net Profit + | 2 | 22 | 5 | 13 | 21 | 15 | 12 |
| EPS in Rs | 2.46 | 25.45 | 6.46 | 14.94 | 25.22 | 17.19 | 14.58 |
| Dividend Payout % | 0% | 11% | 0% | 0% | 0% | 6% | 7% |
Financials of Aarti Surfactant
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 103 | 125 | 128 | 160 | 210 | 224 | 236 |
| Borrowings + | 109 | 152 | 162 | 149 | 99 | 110 | 104 |
| Other Liabilities + | 42 | 102 | 105 | 86 | 105 | 134 | 168 |
| Total Liabilities | 262 | 387 | 402 | 404 | 422 | 477 | 517 |
| Fixed Assets + | 151 | 187 | 173 | 207 | 208 | 204 | 204 |
| CWIP | 14 | 20 | 52 | 8 | 8 | 15 | 41 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 97 | 180 | 178 | 188 | 206 | 259 | 272 |
| Total Assets | 262 | 387 | 402 | 404 | 422 | 477 | 517 |
Financials of Aarti Surfactant
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 18 | 36 | 23 | 25 | 52 | 11 | 77 |
| Cash from Investing Activity + | -2 | -60 | -23 | -11 | -16 | -16 | -46 |
| Cash from Financing Activity + | -16 | 32 | -6 | -8 | -37 | -0 | -20 |
| Net Cash Flow | 0 | 7 | -5 | 6 | -1 | -5 | 12 |
| Free Cash Flow | -7 | -25 | 1 | 14 | 36 | -9 | 32 |
| CFO/OP | 77% | 78% | 78% | 55% | 94% | 39% | 172% |
Financials of Aarti Surfactant
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 43 | 35 | 40 | 43 | 42 | 44 |
| Inventory Days | 83 | 76 | 60 | 60 | 81 | 92 | 60 |
| Days Payable | 28 | 81 | 56 | 44 | 55 | 63 | 62 |
| Cash Conversion Cycle | 75 | 38 | 38 | 55 | 69 | 71 | 43 |
| Working Capital Days | -1 | 3 | 16 | 20 | 40 | 36 | 22 |
| ROCE % | 13% | 7% | 11% | 15% | 8% | 9% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…